Filter Results:
(3,186)
Show Results For
- All HBS Web
(3,186)
- People (7)
- News (425)
- Research (2,382)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,959)
Show Results For
- All HBS Web
(3,186)
- People (7)
- News (425)
- Research (2,382)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,959)
- June 1978 (Revised August 1991)
- Case
Williamstown Community Hospital
Keywords: Health Industry
Herzlinger, Regina E. "Williamstown Community Hospital." Harvard Business School Case 178-226, June 1978. (Revised August 1991.)
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Testing and Trials; Health Care and Treatment; Business Model; Problems and Challenges; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
- 2018
- Working Paper
Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices
By: Prithwiraj Choudhury and Tarun Khanna
We exploit a natural experiment to study how codifying information about prior innovation affects subsequent innovation. A codified database of traditional Indian herbal formulations was adopted by the European Patent Office (EPO) and the U.S. Patent and Trademark... View Details
Keywords: Patents; Plant-Based Agribusiness; Ethnicity; Health Care and Treatment; Pharmaceutical Industry; Pharmaceutical Industry; China; India
Choudhury, Prithwiraj, and Tarun Khanna. "Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices." Harvard Business School Working Paper, No. 14-079, February 2014. (Revised January 2018.)
- February 2002 (Revised August 2002)
- Case
Inhale Therapeutics: Executing and Growing the Business Model
Inhale is about to bring a novel technology to market that uses inhalation to administer drugs that formerly required injection. Inhale must now decide which way to evolve its business model. This will determine the future direction of growth for the company. View Details
Keywords: Business Model; Technological Innovation; Health Care and Treatment; Growth and Development Strategy; Medical Devices and Supplies Industry
Chesbrough, Henry W., and Gillian Morris. "Inhale Therapeutics: Executing and Growing the Business Model." Harvard Business School Case 602-132, February 2002. (Revised August 2002.)
- 01 Dec 2005
- News
MBAs by the Numbers
Job Locations Northeast U.S.: 46.2% (New York City: 26.7%) (Boston: 10.8%) Western U.S.: 17.0% (California Bay Area: 8.7%) Central & Southwest U.S.: 13.7% Southeast U. S.: 5.6% Europe: 8.1% Asia/South Pacific: 5.5% Latin America: 2.1% Other: 1.8% View Details
- November 2008 (Revised July 2009)
- Background Note
A Managerial Perspective on Clinical Trials
By: Arthur A. Daemmrich
This note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Safety; Biotechnology Industry; Biotechnology Industry
Daemmrich, Arthur A. "A Managerial Perspective on Clinical Trials." Harvard Business School Background Note 709-033, November 2008. (Revised July 2009.)
- 13 May 2008
- First Look
First Look: May 13, 2008
community-based health center) are also discussed. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=308072 Global Climate Change and BP Harvard Business School Case 708-026 Following the sudden... View Details
Keywords: Martha Lagace
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
industry practices, which the press juxtaposed against the grim realities of AIDS in southern Africa. In response, governmental and nongovernmental organizations formed a coalition that ultimately won big public View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- Web
IFC: Singapore; Shaping a Global Innovation Hub - Course Catalog
of government programs and financial investment in driving this growth, exploration, and learning will center on a few key questions: The State of Singapore – How does the country’s industrial policy work? Singapore’s View Details
- 01 Jan 2006
- News
Sir Ronald M. Cohen, MBA 1969
Asia, and Israel, it has an international presence and a record of big hits that began in the 1980s with companies such as AOL and Apple and continues to this day with investments in industries as diverse as high tech and View Details
- 26 Sep 2017
- First Look
First Look at New Research and Ideas, September 26, 2017
firm and industry heterogeneity and quasi-exogenous meteorological and sport events. The evidence suggests that family CEOs value—or can pursue—leisure activities relatively more than professional CEOs. Publisher's link:... View Details
Keywords: Sean Silverthorne
- Profile
Paul Wang
researchers was not always as great as that of politics and business. I figured I should jump into the business arena to see what it was like.” Paul joined McKinsey in Chicago, where he worked on projects “with relevance to developing countries, things like energy,... View Details
- Web
Daniela Villafuerte | MBA
in data management and analytics. Data drives the major industries in the world from health and economics to entertainment and government. Through the gathering and analysis of data, optimization and quality... View Details
- Web
Timeline - Race, Gender & Equity
gas-powered automobile built in the U.S. 1894 Boycott of Pullman sleeping cars leads to general strike on railroads Pullman Porters 1900 U.S. Industrial Commission declares trade unions good for democracy 1902 Willis H. Carrier designs... View Details
- February 2008
- Case
SPECIALISTERNE: Sense & Details
Three-quarters of Specialisterne's expert software testing staff are diagnosed with some form of Autistic Spectrum Disorder (ASD). Usually a handicap, ASD conveys talents especially suited to software testing and other highly repetitive tasks that require very high... View Details
Keywords: Business Model; For-Profit Firms; Health Disorders; Employees; Performance Evaluation; Quality; Software; Information Technology Industry
Austin, Robert D., Jonathan Wareham, and Javier Busquets. "SPECIALISTERNE: Sense & Details." Harvard Business School Case 608-109, February 2008.
- Profile
Frank Mycroft
"At HBS, there's such a diversity of industries very different from what I'm used to: finance, consulting, clean energy, health care, etcetera," says Frank. "If I can see how these other View Details
- April 2014 (Revised July 2015)
- Case
Sanofi Pasteur: The Dengue Vaccine Dilemma
By: V. Kasturi Rangan, David E. Bloom, Vincent Dessain and Emilie Billaud
In 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a... View Details
Keywords: Health Testing and Trials; Product Launch; Market Entry and Exit; Emerging Markets; Pharmaceutical Industry; France
Rangan, V. Kasturi, David E. Bloom, Vincent Dessain, and Emilie Billaud. "Sanofi Pasteur: The Dengue Vaccine Dilemma." Harvard Business School Case 514-074, April 2014. (Revised July 2015.)
- June 2004 (Revised November 2004)
- Case
Acorda Therapeutics: Rebuilding the Spinal Cord
Acorda is an early-stage life science start-up with a promising product that is close to reaching the market (Phase III clinical trials). The company is grappling with how to expand its portfolio of molecules to make the business more sustainable. It faces classic... View Details
Keywords: Decision Making; Science-Based Business; Health Testing and Trials; Business Startups; Product Development; Biotechnology Industry
Enriquez-Cabot, Juan, Jonathan West, Marina Kolesnik, and Fiona Murray. "Acorda Therapeutics: Rebuilding the Spinal Cord." Harvard Business School Case 604-014, June 2004. (Revised November 2004.)
- Web
“It’s like a pie-eating contest” | Social Enterprise | Harvard Business School
“It’s like a pie-eating contest” One night during his RC year at HBS, Josh Latson (MBA 2015) shadowed an emergency room physician through his rounds in a busy urban hospital. Josh was there as a member of the school’s Health Care Club,... View Details
- May 2008
- Teaching Note
Disney Consumer Products: Marketing Nutrition to Children (TN)
By: David E. Bell and Mary L. Shelman
Teaching Note for [507-006]. View Details